MECHANISMS OF RESISTANCE TO ENDOCRINE AND BIOLOGICAL AGENTS

被引：0
|
作者：
Johnston, Stephen R. D. [1 ,2 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Breast Lung & Med Oncol Serv CBU, London, England
[2] Inst Canc Res, London, England
来源：
BREAST | 2017年 / 36卷
关键词：
D O I：
10.1016/S0960-9776(17)30632-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IN12
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [31] MECHANISMS OF RESISTANCE TO EGRF AGENTS (MEDICAL IMPLICATIONS)
    Murray, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 43 - 43
  • [32] Resistance to antifungal agents: Mechanisms and clinical impact
    Kanafani, Zeina A.
    Perfect, John R.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (01) : 120 - 128
  • [33] Combinations of endocrine and biological agents: Present status of therapeutic and presurgical investigations
    Johnston, SRD
    CLINICAL CANCER RESEARCH, 2005, 11 (02) : 889S - 899S
  • [34] Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance
    Mitch Dowsett
    Robert I. Nicholson
    Richard J. Pietras
    Breast Cancer Research and Treatment, 2005, 93 : 11 - 18
  • [35] Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
    H Aguilar
    X Solé
    N Bonifaci
    J Serra-Musach
    A Islam
    N López-Bigas
    M Méndez-Pertuz
    R L Beijersbergen
    C Lázaro
    A Urruticoechea
    M A Pujana
    Oncogene, 2010, 29 : 6071 - 6083
  • [36] Pathogenetic mechanisms of biological agents in managing of relapsing polychondritis
    Khaleva, E. G.
    Novik, G. A.
    Rokhlina, F., V
    BYULLETEN SIBIRSKOY MEDITSINY, 2018, 17 (02): : 167 - 174
  • [37] Biological reprogramming in acquired resistance to endocrine therapy of breast cancer
    Aguilar, H.
    Sole, X.
    Bonifaci, N.
    Serra-Musach, J.
    Islam, A.
    Lopez-Bigas, N.
    Mendez-Pertuz, M.
    Beijersbergen, R. L.
    Lazaro, C.
    Urruticoechea, A.
    Pujana, M. A.
    ONCOGENE, 2010, 29 (45) : 6071 - 6083
  • [38] Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance
    Dowsett, M
    Nicholson, RI
    Pietras, RJ
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 93 (Suppl 1) : S11 - S18
  • [39] Novel mechanisms of resistance to endocrine therapy: Genomic and nongenomic considerations
    Gururaj, AE
    Rayala, SK
    Vadlamudi, RK
    Kumar, R
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 1001S - 1007S
  • [40] Neoadjuvant Endocrine Therapy: Retrospective Analysis of Some Mechanisms of Resistance
    Semiglazov, V. F.
    Manikhas, A. G.
    Semiglazov, V. V.
    Dashyan, G. A.
    Ivanov, V. G.
    Paltuev, R. M.
    Zhiltsova, E. K.
    Bozhok, A. A.
    Skvortsov, V. V.
    Raskin, G. G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S171 - S171
12345